Joseph Truitt - 17 May 2023 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role
Director
Signature
/s/ Jennifer Johansson, Attorney-in-fact
Issuer symbol
LRMR
Transactions as of
17 May 2023
Net transactions value
+$10,258
Form type
4
Filing time
18 May 2023, 14:12:44 UTC
Previous filing
11 May 2023
Next filing
31 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRMR Common Stock Purchase $10,258 +2,750 $3.73 2,750 17 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.